2025
conference-abstract
OpenAlex
Ashley Lui, Marco Napoli, Julia Nowak, Mayayi Izzo et autres
Abstract High-grade serous ovarian cancer (HGSOC) is the most common and malignant type of ovarian cancer. Even though roughly 85% of patients achieve remission after initial surgical debulking and chemotherapy, four out of five HGSOC patients will experience disease recurrence, resulting in …
us
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Yuxi Zhou, Alfonso Pepe, Ryan Smolchek, Jack E. Famiglietti et autres
Abstract Background: High-grade serous ovarian cancer (HGSOC) remains a leading cause of gynecologic cancer-related mortality, with limited treatment options. Although initial remission is often achieved through surgery and chemotherapy, disease recurrence is common. Existing preclinical models fail to fully recapitulate the complexity …
us
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Paul Castillo, Elizabeth Ogando‐Rivas, Hilary Geffrard, Alfonso Pepe et autres
Abstract BACKGROUND Checkpoint inhibition has emerged as a promising cancer therapeutic approach. Checkpoint inhibitors (CIs) function by overcoming the adaptive T cell exhaustion induced by solid tumor microenvironment including brain tumors, particularly in the neoadjuvant setting. Unfortunately, not every patient who receives …
us
(code pays fourni par la source)
2021
article
OpenAlex
Qin Yu, Nicky Craig, Rachel C. Newsome, M. C. Carreño Hernández et autres
2018
article
OpenAlex
Tristan T. Hormel, Tapomoy Bhattacharjee, Christopher S. O’Bryan, Gregory W. Sawyer et autres
2017
article
OpenAlex
Alexander McGhee, Alexander I. Bennett, Peter Ifju, Gregory W. Sawyer et autres
us
(code pays fourni par la source)
2017
article
OpenAlex
Tristan T. Hormel, Tapomoy Bhattacharjee, Angela A. Pitenis, Juan Manuel Urueña et autres
2013
book-chapter
OpenAlex
Gregory W. Sawyer, Frederick J. Ehlert
The use of in vitro mutagenesis to characterize structure-function relationships in G protein-coupled receptors has led to the identification of specific amino acid residues that contribute to ligand binding, G protein coupling, and receptor folding. Mutagenesis is commonly used to change or …
us
(code pays fourni par la source)
2013
article
OpenAlex
Gregory W. Sawyer, Crystal A. Shults
In this investigation, we determined whether membrane permeable muscarinic receptor selective agonists, antagonists, and allosteric ligands cause a mutant M 1 muscarinic receptor to traffic from ER to the plasma membrane of CHO cells. This receptor, M 1LL/AA , possesses a L430A/L431A …
us
(code pays fourni par la source)
2012
article
OpenAlex
Steven M. Zehnder, Jolie Breaux, Alison C. Dunn, Gregory W. Sawyer et autres
2011
book-chapter
OpenAlex
Gregory W. Sawyer
A new approach for characterizing the plasma membrane delivery of G protein-coupled receptors is described in this chapter. This approach uses an existing technology, the regulated secretion/aggregation technology (RPD ™ ), to cause the accumulation of G protein-coupled receptors in the ER …
us
(code pays fourni par la source)
Accès ouvert
2010
article
OpenAlex
Arunkumar Thangaraju, Gregory W. Sawyer
us
(code pays fourni par la source)